Nova Patents
PL2914291T3

Anti-complement c1s antibodies and uses thereof

Abstract

This record has no abstract on file.

Term

7.1 yearsto projected expiry

Projected expiry 1 November 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

64 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
201261721916United States of AmericaP
201361754123United States of AmericaP
201361779180United States of AmericaP
201361846402United States of AmericaP
2013068095United States of AmericaW

Members64

Family members, oldest first
DocumentOfficeKind
GB201403961D0United KingdomD0
CA2889197A1CanadaA1
US2014127196A1United States of AmericaA1
US2014127208A1United States of AmericaA1
WO2014071206A1World Intellectual Property Organization (WIPO)A1
US2014140933A1United States of AmericaA1
GB2509260AUnited KingdomA
US8877197B2United States of AmericaB2
US8945562B2United States of AmericaB2
US2015104448A1United States of AmericaA1
AU2013337638A1AustraliaA1
US9074003B2United States of AmericaB2
US9074004B2United States of AmericaB2
CN104884088AChinaA
EP2914291A1European Patent Office (EPO)A1
US2015307626A1United States of AmericaA1
US9206259B2United States of AmericaB2
JP2016505240AJapanA
US2016053002A1United States of AmericaA1
GB2509260BUnited KingdomB
EP2914291A4European Patent Office (EPO)A4
US9562092B2United States of AmericaB2
US2017226230A1United States of AmericaA1
CN104884088BChinaB
CN108610418AChinaA
AU2013337638B2AustraliaB2
AU2019200448A1AustraliaA1
JP6543572B2JapanB2
US10450382B2United States of AmericaB2
JP2019194210AJapanA
US2020079875A1United States of AmericaA1
AU2019200448B2AustraliaB2
JP6860618B2JapanB2
AU2021201759A1AustraliaA1
JP2021104029AJapanA
EP3906944A1European Patent Office (EPO)A1
EP3906944A4European Patent Office (EPO)A4
EP2914291B1European Patent Office (EPO)B1
PT2914291TPortugalT
FI2914291T3FinlandT3
DK2914291T3DenmarkT3
ES2912396T3SpainT3
LT2914291TLithuaniaT
HRP20220637T1CroatiaT1
RS63212B1SerbiaB1
US2022204647A1United States of AmericaA1
PL2914291T3This recordPolandT3
CN108610418BChinaB
JP7210629B2JapanB2
JP2023052318AJapanA
LTPA2023510I1LithuaniaI1
FIC20230015I1FinlandI1
NO2023018I1NorwayI1
CN116063483AChinaA
NL301232I1Netherlands (Kingdom of the)I1
HUS2300017I1HungaryI1
FR23C1019I1FranceI1
NL301232I2Netherlands (Kingdom of the)I2
FR23C1019I2FranceI2
AU2024227570A1AustraliaA1
US12240917B2United States of AmericaB2
LTC2914291I2LithuaniaI2
US2025188192A1United States of AmericaA1
LUC00303I2LuxembourgI2